CHARACTERIZATION OF RECOMBINANT GLUTAMATE RECEPTORS
重组谷氨酸受体的表征
基本信息
- 批准号:2268921
- 负责人:
- 金额:$ 18.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-09-30 至 1996-04-30
- 项目状态:已结题
- 来源:
- 关键词:Xenopus oocyte antibody formation cerebellum cerebral cortex chimeric proteins excitatory aminoacid glutamate receptor glutamates hippocampus kainate laboratory rabbit laboratory rat messenger RNA molecular cloning molecular site peptides polymerase chain reaction prosencephalon protein sequence protein structure protein structure function receptor binding receptor expression recombinant DNA recombinant proteins site directed mutagenesis spinal cord voltage /patch clamp western blottings
项目摘要
Experiments are proposed to study the structure and function of
recombinant glutamate receptors of the
alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) and kainate
subtypes. The functional properties of native and recombinant receptors
expressed in Xenopus oocytes will be compared using electrophysiological
methods. The levels of AMPA or kainate receptor subunits in brain
derived RNAs will be quantitated by polymerase chain reaction (PCR) and
correlations will be made between functional properties and possible
subunit structure. These correlations will be tested by measuring the
functional properties of recombinant receptors expressed from identical
amounts of the those subunits found in brain mRNA preparations.
Development of subunit-specific antibodies directed against peptides
found in the cloned amino acid sequences is also proposed. Useful
antibodies will help directly probe the subunit structure of native
receptors by Western blot analysis and high resolution
immunolocalization. To identify and characterize the agonist and
antagonist binding sites within the substructures of individual subunits,
purposeful alterations in structure of the subunits will be introduced
using recombinant DNA technology. The effects of these alterations on
the potencies of agonists and antagonists will be measured with two
electrode voltage clamp of Xenopus oocytes. Kinetic studies using rapid
application techniques in patch clamped fibroblasts transiently
expressing receptor subunits will be used to dissect the molecular
mechanism of ligand binding and unbinding. These studies are designed to
increase our understanding of neuronal AMPA and kainate receptors and
lead toward the development of useful therapeutic compounds that act on
these, receptors. The AMPA and kainate receptor systems are implicated
in a number of pathological processes including neuronal damage resulting
from cerebral ischemia, Parkinson's disease, epilepsy and psychosis.
提出了实验研究的结构和功能
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TODD A VERDOORN其他文献
TODD A VERDOORN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TODD A VERDOORN', 18)}}的其他基金
Ion channel targets for treatment of neuropathic pain
治疗神经性疼痛的离子通道靶点
- 批准号:
6739208 - 财政年份:2003
- 资助金额:
$ 18.89万 - 项目类别:
AMINO ACID NEUROTRANSMITTERS IN THE ENDOCRINE PANCREAS
内分泌胰腺中的氨基酸神经递质
- 批准号:
2152611 - 财政年份:1996
- 资助金额:
$ 18.89万 - 项目类别:
FUNCTIONAL STUDIES OF CLONED GLUTAMATE AND GABA RECEPTOR
克隆谷氨酸和GABA受体的功能研究
- 批准号:
3510015 - 财政年份:1992
- 资助金额:
$ 18.89万 - 项目类别:
CHARACTERIZATION OF RECOMBINANT GLUTAMATE RECEPTORS
重组谷氨酸受体的表征
- 批准号:
2268922 - 财政年份:1992
- 资助金额:
$ 18.89万 - 项目类别:
相似海外基金
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9981001 - 财政年份:2017
- 资助金额:
$ 18.89万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9751102 - 财政年份:2017
- 资助金额:
$ 18.89万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9397073 - 财政年份:2017
- 资助金额:
$ 18.89万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
10223410 - 财政年份:2017
- 资助金额:
$ 18.89万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
- 批准号:
7951676 - 财政年份:2008
- 资助金额:
$ 18.89万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
- 批准号:
7606036 - 财政年份:2006
- 资助金额:
$ 18.89万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7375053 - 财政年份:2005
- 资助金额:
$ 18.89万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7201220 - 财政年份:2004
- 资助金额:
$ 18.89万 - 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
- 批准号:
6980810 - 财政年份:2003
- 资助金额:
$ 18.89万 - 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
- 批准号:
6419444 - 财政年份:2000
- 资助金额:
$ 18.89万 - 项目类别:














{{item.name}}会员




